Frances H. Arnold, California Institute of Technology
Alan Cherney, Amgen, Inc.
Christian Harrison, Vertex Pharmaceuticals Incorporated
Kami L. Hull,
University of Texas, Austin
Robert Knowles, Princeton University
Theodore Martinot, Merck & Co.
Eric Meggers
, Philipps University Marburg
Scott Plummer, Novartis Institutes for BioMedical Research

8:00 AM Registration and continental breakfast
8:30 AM Morning session
12:00 PM Lunch
1:15 PM Afternoon session
5:00 PM Reception


8:00 AM Breakfast
Morning Session

8:30 AM
Welcome and Introductory Remarks
Mark Hellberg (Novartis) & Katherine Lee (NESACS)
8:40 AM
Robert R. Knowles (Princeton University)
Proton-coupled electron transfer in organic synthesis
9:40 AM Cristian Harrison (Vertex)
Process Development in the Synthesis of CF Corrector VX-661

10:10 AM Break

10:30 AM Theodore Martinot (Merck)
Process Safety Assessment and Route Selection Strategy for the Synthesis of Substituted Oxadiazoles
11:00 AM Frances H. Arnold (California Institute of Technology)
Innovation by Evolution: Bringing New Chemistry to Life

12:00 AM Lunch
Afternoon Session

1:30 PM Kami Hull (University of Texas)
Transition Metal-Catalyzed Amination and Amidation Reactions
2:30 PM Scott Plummer (Novartis)
Aqueous Surfactant Technology at Novartis: Sustainability as a Trigger for Innovation

3:00 PM Break

3:20 PM Alan H. Cherney (Amgen)
Development of a Branch-Selective Cross-Coupling of Heteroaryl Halides and sec-Alkylzinc Reagents
3:50 PM Eric Meggers (Philipps-Universität Marburg)
"Chiral-at-Metal" Complexes Applied to Asymmetric Catalysis
4:50 PM Concluding Remarks

5:00 PM Reception